1 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Austin I Kim: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Avo In R/R And Previously Untreated MCL Acalabrutinib, Venetoclax, Obinutuzumab - Mantle Cell Lymphoma, Refractory Lymphoma | Phase 1 / Phase 2 | Recruiting | Austin I Kim | 72 | 2021-07-02 | 2026-01-21 |
Lymphoma (1) · Lymphoma, Mantle-Cell (1)
acalabrutinib (1) · obinutuzumab (1) · venetoclax (1)
United States (1)